-
1.Crystalline Form of Bis [(E)-7-[4-(4-fluoro-phenyl)-6-isopropyl-2-[methyl(methyl-sulfonyl)amino] pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt 审中-公开
Title translation: 双[(E)-7- [4-(4-氟 - 苯基)-6-异丙基-2- [甲基(甲基 - 磺酰基)氨基]嘧啶-5-基](3R,5S)-3 ,5-二羟基庚-6-烯酸]钙盐公开(公告)号:US20100222373A1
公开(公告)日:2010-09-02
申请号:US12615935
申请日:2009-11-10
Applicant: Rebecca Jane Booth , Peter Anthony Cittern , Jeffrey Norman Crabb , John Horbury , David Way Calvert Jones
Inventor: Rebecca Jane Booth , Peter Anthony Cittern , Jeffrey Norman Crabb , John Horbury , David Way Calvert Jones
IPC: A61K31/505 , C07D239/42 , A61P3/06 , A61P9/10
CPC classification number: C07D239/42
Abstract: Two polymorphic forms of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt, processes for making them and their use as HMG Co-A reductase inhibitors are described.
Abstract translation: 双[(E)-7- [4-(4-氟苯基)-6-异丙基-2- [甲基(甲基磺酰基)氨基]嘧啶-5-基](3R,5S)-3,5-二 二羟基庚-6-烯酸]钙盐,其制备方法及其作为HMG Co-A还原酶抑制剂的用途。